EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of vitamin D supplementation on interleukin-17 in children with nephrotic syndrome

Ichsan Noor, Jusli Jusli, St. Aizah Lawang, A. Dwi Bahagia Febriani, Ratna Dewi Artati, Urfianty Urfianty

Romanian Journal of Pediatrics · 30.06.2026 · 75 (2) · 83

DOI: 10.37897/rjp.2026.2.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Romanian Journal of Pediatrics, online erschienen am 30.06.2026. Verfasst von Ichsan Noor und 5 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives. Nephrotic syndrome (NS) is characterized by massive proteinuria, which may lead to urinary loss of vitamin D-binding protein and subsequent vitamin D deficiency. Vitamin D has immunomodulatory effects mediated through vitamin D receptor activation, including modulation of the T helper 17 (Th17) pathway and interleukin-17 (IL-17), a cytokine involved in podocyte injury and inflammation. This study evaluated the effects of two doses of vitamin D₃ supplementation on serum 25-hydroxyvitamin D [25(OH)D] and IL-17 levels in children with NS. Materials and methods. In this randomized, double-blind, controlled trial, children aged 1-18 years with NS were allocated to receive standard therapy plus oral vitamin D₃ at either 400 IU/day (Group I) or 1000 IU/day (Group II) for four weeks. Serum 25(OH)D and IL-17 concentrations were measured at baseline and after the intervention. Within-group and between-group analyses were performed to assess changes in these parameters.

Results

After four weeks, serum 25(OH)D levels increased significantly in both groups. The median increase was 4.7 ng/mL in Group I (p = 0.001) and 5.1 ng/mL in Group II (p = 0.018), with no significant difference between groups (p = 0.903). IL-17 levels decreased in both groups; however, these reductions were not statistically significant. The median change was −0.26 pg/mL in Group I (p = 0.057) and −0.18 pg/mL in Group II (p = 0.469), with no significant between-group difference (p = 0.682).

Conclusions

Vitamin D₃ supplementation at 400 IU/day and 1000 IU/day modestly increased serum 25(OH)D levels in children with NS but did not significantly reduce IL-17 levels over four weeks. The short intervention duration, relatively low supplementation doses, and persistent proteinuria may have limited the detectable immunomodulatory effects of vitamin D in this population.

Zitieren

APA

Noor, I., Jusli, J., Lawang, S. A., Febriani, A. D. B., Artati, R. D., & Urfianty, U. (2026). Effects of vitamin D supplementation on interleukin-17 in children with nephrotic syndrome. Romanian Journal of Pediatrics, 75(2), 83. https://doi.org/10.37897/rjp.2026.2.2

Vancouver

Noor I, Jusli J, Lawang SA, Febriani ADB, Artati RD, Urfianty U. Effects of vitamin D supplementation on interleukin-17 in children with nephrotic syndrome. Romanian Journal of Pediatrics. 2026;75(2):83. doi:10.37897/rjp.2026.2.2

BibTeX
@article{Noor2026,
  author = {Noor, Ichsan and Jusli, Jusli and Lawang, St. Aizah and Febriani, A. Dwi Bahagia and Artati, Ratna Dewi and Urfianty, Urfianty},
  title = {Effects of vitamin D supplementation on interleukin-17 in children with nephrotic syndrome},
  journal = {Romanian Journal of Pediatrics},
  year = {2026},
  volume = {75},
  number = {2},
  pages = {83},
  doi = {10.37897/rjp.2026.2.2}
}
Kostenlos starten →